Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

INVOLVEMENT OF MOLYBDENUM HYDROXYLASES IN REDUCTIVE METABOLISM OF NITRO POLYCYCLIC AROMATIC HYDROCARBONS IN MAMMALIAN SKIN

Osamu Ueda, Kazumi Sugihara, Shigeru Ohta and Shigeyuki Kitamura
Drug Metabolism and Disposition September 2005, 33 (9) 1312-1318; DOI: https://doi.org/10.1124/dmd.105.005306
Osamu Ueda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazumi Sugihara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Ohta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeyuki Kitamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Molybdenum hydroxylases, aldehyde oxidase and xanthine oxidoreductase, were shown to be involved in the nitroreduction of 2-nitrofluorene (NF), 1-nitropyrene, and 4-nitrobiphenyl, environmental pollutants, in the skin of various mammalian species. NF was reduced to 2-aminofluorene by hamster skin cytosol in the presence of 2-hydroxypyrimidine, 4-hydroxypyrimidine, N1-methylnicotinamide, or benzaldehyde, but not hypoxanthine or xanthine. Inhibitors of aldehyde oxidase markedly inhibited these nitroreductase activities, but oxypurinol, an inhibitor of xanthine oxidoreductase, had little effect. In DEAE column chromatography of hamster skin cytosol, the major fraction exhibiting nitroreductase activity also showed aldehyde oxidase activity. 2-Hydroxypyrimidine-linked nitroreductase activities of skin cytosol from rabbits and guinea pigs were also inhibited by an inhibitor of aldehyde oxidase. In contrast, nitroreductase activities of skin cytosols of rats and mice were markedly inhibited by oxypurinol. When aldehyde oxidase activity was estimated in skin cytosol of various mammals using benzaldehyde oxidase activity as a marker, considerable variability of the activity was found. The highest activity was observed with hamsters, and the lowest activity with rats. On the other hand, the highest xanthine oxidoreductase activity was observed with rats, and the lowest activity with rabbits. These skin cytosols of various mammals also exhibited significant 2-hydroxypyrimidine-linked nitroreductase activities toward 1-nitropyrene and 4-nitrobiphenyl catalyzed by aldehyde oxidase and xanthine oxidoreductase. Thus, NF was mainly reduced by aldehyde oxidase and xanthine oxidoreductase in skins of animals. However, the contributions of these two molybdenum hydroxylases were considerably different among animal species.

Nitrated polycyclic aromatic hydrocarbons (nitro-PAHs) are widely distributed in the environment, chiefly as the result of incomplete combustion processes, and have various biological activities including mutagenicity and carcinogenicity through skin contact (El-Bayoumy et al., 1982; Beije and Möller, 1988; Purohit and Basu, 2000). 2-Nitrofluorene (NF) is classified as a nitro-PAH and requires metabolic activation, being converted into electrophilic metabolites, which ultimately bind to cellular macromolecules. Reduction of the nitro group is thought to be a key step in the metabolic activation (Fu, 1990). In addition, nitroreduction is considered the major reaction in the metabolism of NF in vivo (Möller et al., 1987; Ueda et al., 2001). Therefore, the nitroreduction of these compounds in animal livers has been investigated extensively, and it was reported that the reductive metabolism of nitro-PAHs is catalyzed by cytochrome P450, aldehyde oxidase, and/or xanthine oxidoreductase in mammalian liver (Saito et al., 1984; Tatsumi et al., 1986; Bauer and Howard, 1990).

Recently, we examined reductive metabolism of NF in rat skin preparations and showed that nitroreduction in skin was mainly catalyzed by cytosolic xanthine oxidoreductase, but not by microsomal cytochrome P450, cytosolic aldehyde oxidase, or DT-diaphorase (Ueda et al., 2003). However, an earlier study using rabbit liver had shown that aldehyde oxidase played a major role in the reduction of NF and other nitro-PAHs (Tatsumi et al., 1986). In sea bream liver, nitroreduction of NF was catalyzed by aldehyde oxidase (Ueda et al., 2002). Furthermore, our preliminary study using rat liver found that aldehyde oxidase was mainly involved in reduction of NF, with xanthine oxidoreductase playing a lesser role. These facts suggested that both of the molybdenum hydroxylases contribute to the nitroreduction of nitro-PAHs in mammalian tissues, especially in skin, which is one of target organs for environmental contaminants.

Moreover, there are marked species differences and strain differences (in rats and mice) of liver aldehyde oxidase (Krenitsky et al., 1974; Sugihara et al., 1995; Rashidi et al., 1997; Kitamura et al., 1999a). For example, in liver, high aldehyde oxidase activity is observed in rabbits and hamsters. Therefore, the enzyme primarily responsible for nitroreduction of nitro-PAHs in skin may well be species-dependent.

In the present study, we demonstrated the involvement of both aldehyde oxidase and xanthine oxidoreductase in nitroreduction of nitro-PAHs in skin cytosols of various mammals. Furthermore, the relative contributions of these molybdenum hydroxylases to the nitroreduction in skin cytosols of various mammals were determined.

Materials and Methods

Chemicals. NF, 1-nitropyrene (NP), 4-nitrobiphenyl (NB), 2-aminofluorene, 1-aminopyrene, 4-aminobiphenyl, 2-hydroxypyrimidine hydrochloride, 4-hydroxypyrimidine, xanthine, 1-methylxanthine and benzaldehyde were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). N1-Methylnicotinamide, menadione, chlorpromazine, quercetin dihydrate, isovanillin, oxypurinol, hypoxanthine, and phenylmethylsulfonyl fluoride were obtained from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Other chemicals used were of the highest grade commercially available.

Animals. Male Syrian Golden hamsters (65–80 g), Japanese albino rabbits (2.0–2.5 kg), Hartley guinea pigs (150–190 g), and ddY mice (23–30 g) were purchased from Japan SLC Inc. (Shizuoka, Japan). Sea/Sprague-Dawley rats (200–240 g) were purchased from Seiwa Experimental Animals, Ltd. (Fukuoka, Japan).

Preparation of Skin Cytosol. Skin cytosol and microsomes were prepared by using a reported method (Ueda et al., 2003). Briefly, the skin was excised, and subcutaneous tissues were scraped off with scissors. Scraped sheets of skin were homogenized with 3 volumes of 0.1 M potassium/sodium phosphate buffer (pH 7.4) containing 0.1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM EDTA, and 0.1 mM ethylene glycol bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (buffer A). Microsomes and cytosol were obtained from the homogenate by successive centrifugation at 9000g for 20 min and at 105,000g for 90 min.

DEAE-Cellulose Column Chromatography. The skin cytosolic fraction was subjected to ammonium sulfate fractionation, and proteins that precipitated between 30% and 60% ammonium sulfate saturation were collected. The precipitate was dissolved in buffer A, and dialyzed against 200 volumes of 10-fold-diluted buffer A for 12 h. The dialyzed solution was centrifuged at 9000g for 20 min, and the supernatant was adsorbed on a column (1.5 × 12 cm) of DE-52, which was equilibrated with buffer A. The column was washed with 50-ml buffer A and eluted with a 100-ml linear gradient of 0 to 0.3 M sodium chloride in buffer A. The fractions were assayed for aldehyde oxidase activity, xanthine oxidase activity, and nitroreductase activity toward NF in the presence of 2-hydroxypyrimidine, and the active fractions were pooled and stored at –80°C.

Assays of Nitroreductase Activity. The incubation mixture consisted of 0.1 μmol of NF, NP, or NB, 0.5 μmol of an electron donor, and a skin preparation in a final volume of 1 ml of 0.1 M potassium/sodium phosphate buffer (pH 7.4). The incubation was performed at 37°C for 30 min under an atmosphere of nitrogen using a Thunberg tube. The protein concentration used in assays was 2 mg/ml. In some cases, incubation was also performed in the presence of 10 μM menadione; 100 μM isovanillin, quercetin, or chlorpromazine, which are potent inhibitors of aldehyde oxidase; or 100 μM oxypurinol, an inhibitor of xanthine oxidoreductase. After incubation, 50 μg of phenacetin was added to the mixture as an internal standard, and then the mixture was extracted with 7 ml of ethyl acetate. The extract was evaporated to dryness in vacuo and the residue was subjected to high-performance liquid chromatography (HPLC). Nitroreductase activity was determined by measuring amino derivatives formed from NF, NP, and NB.

Assay of Aldehyde Oxidase Activity. Aldehyde oxidase activity was measured in terms of the oxidation of benzaldehyde to benzoic acid. Each incubation mixture consisted of 0.1 μmol of benzaldehyde and skin cytosol in a final volume of 0.5 ml of 0.1 M potassium/sodium phosphate buffer (pH 7.4). The incubation was performed at 37°C for 15 min. The protein concentration used in assays was 1 mg/ml. After incubation, the reaction was stopped by addition of 500 μl of methanol, and 50 μg of estriol was added to the mixture as an internal standard. After mixing, the solution was centrifuged at 10,000 rpm for 5 min. An aliquot of the supernatant was subjected to HPLC.

Assays of Xanthine Oxidoreductase (Xanthine Oxidase and Xanthine Dehydrogenase) Activities. Xanthine oxidase activity in skin cytosol was measured in terms of the oxidation of 1-methylxanthine to 1-methyluric acid in the absence of NAD. In the case of xanthine dehydrogenase activity, 0.27 μmol of NAD was added to the incubation mixture. Each incubation mixture consisted of 0.1 μmol of 1-methylxanthine and skin cytosol in a final volume of 0.5 ml of 0.1 M potassium/sodium phosphate buffer (pH 7.4). The incubation was performed at 37°C for 20 min. The protein concentration used in assays was 2 mg/ml. After incubation, the reaction was stopped by addition of 500 μl of methanol, and 50 μg of acetaminophen was added to the mixture as an internal standard. After mixing, the solution was centrifuged at 10,000 rpm for 5 min, and an aliquot of the supernatant was subjected to HPLC. In this study, xanthine oxidoreductase activity was expressed as the total of xanthine oxidase and xanthine dehydrogenase activities.

HPLC. HPLC was performed in an LC-10ADvp (Shimadzu Co., Ltd., Kyoto, Japan) chromatograph fitted with a 250 × 4.6 mm column of CAPCELL PAK C18 UG120 S-5 μm (Shiseido Co., Ltd., Tokyo, Japan). For the determination of 2-aminofluorene, 1-aminopyrene, or 4-aminobiphenyl, the column was operated at a flow rate of 0.7 ml/min of acetonitrile/water (6:4) at 40°C, using phenacetin as an internal standard, with the detector set at 280 nm. Retention times of authentic phenacetin (an internal standard), 4-aminobiphenyl, 2-aminofluorene, 1-aminopyrene, NB, NF, and NP were 5.1, 8.5, 8.8, 13.6, 17.0, 18.9, and 30.7 min, respectively. For the determination of benzoic acid, the column was operated at a flow rate of 0.5 ml/min of 0.5% acetic acid/acetonitrile (1:1) at 40°C, using estriol as an internal standard, with the detector set at 272 nm. Retention times of authentic estriol (an internal standard), benzoic acid, and benzaldehyde were 6.5, 7.6, and 10.0 min, respectively. For the determination of 1-methyluric acid, the column was operated at a flow rate of 0.5 ml/min of 0.5% acetic acid/methanol (9:1) at 40°C, using acetaminophen as an internal standard, with the detector set at 280 nm. Retention times of authentic acetaminophen (an internal standard), 1-methyluric acid, and 1-methylxanthine were 11.3, 14.0, and 17.1 min, respectively.

Results

Nitroreduction of NF in Hamster Skin Preparations. Nitroreductase activity toward NF in hamster skin microsomes and cytosol in the presence of various electron donors was examined. The skin cytosol exhibited significant nitroreductase activity with 2-hydroxypyrimidine or 4-hydroxypyrimidine (electron donors of aldehyde oxidase and xanthine oxidoreductase), and N1-methylnicotinamide or benzaldehyde (electron donors of aldehyde oxidase). However, NADPH and NADH (electron donors of DT-diaphorase) or hypoxanthine, xanthine, and 1-methylxanthine (electron donors of xanthine oxidoreductase) had no effect on the activity (Fig. 1A). The 2-hydroxypyrimidine- or 4-hydroxypyrimidine-linked nitroreductase activity was markedly inhibited by menadione, isovanillin, chlorpromazine, and quercetin (inhibitors of aldehyde oxidase), but oxypurinol, an inhibitor of xanthine oxidoreductase, had little effect. Moreover, N1-methylnicotinamide- or benzaldehyde-linked activity was completely inhibited by menadione, but not by oxypurinol (Fig. 1B). In contrast, microsomal nitroreductase activity was enhanced with NADPH, but the full activity (3.5 pmol/min/mg protein) was much lower than that of skin cytosol. These facts suggest that the nitroreduction by hamster skin cytosol is mainly due to aldehyde oxidase.

DEAE Column Chromatography of Hamster Skin Cytosol. The hamster skin cytosol was subjected to DEAE-cellulose column chromatography, and the fractions were assayed for nitroreductase activity in the presence of 2-hydroxypyrimidine, as well as for aldehyde oxidase and xanthine oxidase activities. The fractions that exhibited 2-hydroxypyrimidine-linked nitroreductase activity were separated into two active fractions. The minor active fractions (fraction I; fraction 26–32) were coeluted with xanthine oxidoreductase, and the major active fractions (fraction II; fraction 37–46) were coeluted with aldehyde oxidase (Fig. 2).

Fraction I exhibited nitroreductase activity in the presence of 2-hydroxypyrimidine or hypoxanthine. The 2-hydroxypyrimidine-linked nitroreductase activity of fraction I was inhibited by oxypurinol, but not by menadione. On the other hand, the nitroreductase activity of fraction II was enhanced by addition of 2-hydroxypyrimidine, N1-methylnicotinamide, and benzaldehyde, but not by hypoxanthine. The 2-hydroxypyrimidine-linked nitroreductase activity was inhibited by menadione, but not by oxypurinol (Fig. 3). These results confirmed that the nitroreductase activities in fractions I and II are due to xanthine oxidoreductase and aldehyde oxidase, respectively. Fraction II accounted for the majority of the nitroreductase activity in hamster skin cytosol.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Reduction of 2-nitrofluorene to 2-aminofluorene by hamster skin cytosol. Each bar represents the mean ± S.D. of four hamsters. A, requirement of electron donor. B, the effects of inhibitors on 2-hydroxypyrimidine-, 4-hydroxypyrimidine-, N1-methylnicotinamide-, or benzaldehyde-linked nitroreductase activity. Incubation was performed at 37°C for 30 min with 2.0 mg/ml skin cytosol with various electron donors in the presence or absence of an inhibitor under anaerobic conditions. Open column, in the absence of an inhibitor; hatched column, in the presence of an inhibitor. Menadione was added at 1 × 10–5 M, and isovanillin, chlorpromazine, quercetin, and oxypurinol were added at 1 × 10–4 M. The amount of 2-aminofluorene formed was determined by HPLC. Other details are described under Materials and Methods. **, p < 0.05 compared with control. ND, not detected.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

DEAE-cellulose column chromatography of 2-hydroxypyrimidine-linked nitroreductase (○), xanthine oxidase (▴), and aldehyde oxidase (•) in ammonium sulfate precipitate (30–60%) from hamster skin cytosol. In the assay of 2-nitrofluorene nitroreductase, the incubation mixture consisted of 0.1 μmol of 2-nitrofluorene, 0.5 μmol of 2-hydroxypyrimidine, and 0.2 ml of each fraction in a final volume of 1 ml of 0.1 M potassium/sodium phosphate buffer (pH 7.4). The incubation was performed at 37°C for 30 min under anaerobic conditions. Other details are described under Materials and Methods.

Nitroreduction of NF in Skin Cytosols of Various Mammals.

2-Hydroxypyrimidine-linked nitroreductase activity toward NF in skin cytosol of various mammals was examined. The skin cytosols of rabbits, guinea pigs, mice, and rats all exhibited significant nitroreductase activity. The effects of various chemicals were then examined. In rabbits, similar to hamster, the nitroreductase activity in skin cytosol was markedly inhibited by menadione, but not by oxypurinol. In skin of guinea pigs, the nitroreductase activity was partly inhibited by both oxypurinol and menadione. Moreover, the activities in skin cytosols of mice and rats were significantly inhibited by oxypurinol but little affected by menadione (Fig. 4). These results suggest that aldehyde oxidase participates predominantly in nitroreduction of NF in skins of hamsters and rabbits, whereas xanthine oxidoreductase participates predominantly in mice and rats, and both flavoenzymes participate in guinea pigs.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Reduction of 2-nitrofluorene to 2-aminofluorene by fraction I and fraction II separated by DEAE-cellulose column chromatography. Each bar represents the mean ± S.D. of three experiments. The incubation was performed at 37°C for 30 min with 0.1 ml of fraction I or fraction II and various electron donors under anaerobic conditions. Menadione was added at 1 × 10–5 M, and oxypurinol was added at 1 × 10–4 M. The amount of 2-aminofluorene formed was determined by HPLC. Other details are described under Materials and Methods. **, p < 0.05 compared with control.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Reduction of 2-nitrofluorene to 2-aminofluorene by skin cytosol from various mammals. Each value represents the mean ± S.D. of three or four animals. Incubation was performed at 37°C for 30 min with 0.1 to 0.3 ml of skin cytosol (2.0 mg/ml) with 2-hydroxypyrimidine in the presence or absence of an inhibitor under anaerobic conditions. Menadione was added at 1 × 10–5 M, and oxypurinol was added at 1 × 10–4 M. The amount of 2-aminofluorene formed was determined by HPLC. Other details are described under Materials and Methods. **, p < 0.05 compared with control.

Aldehyde Oxidase and Xanthine Oxidoreductase Activities in Skin Cytosol. When aldehyde oxidase activity in skin cytosol was measured in terms of the oxidation of benzaldehyde, the highest activity was observed with hamsters, followed by rabbits and guinea pigs. In mice and rats, the activities were slight. The difference in the activity between hamsters and rats was about 6-fold. When xanthine oxidase activity was assayed in the absence of NAD, marked differences were found in skin cytosols from various mammals (Table 1). The activities were completely inhibited by oxypurinol, but not menadione (data not shown). The highest activity was observed with rats, followed by mice, guinea pigs, and hamsters. However, very low activity was observed in rabbits. The difference in activity between rats and rabbits was 25-fold. Species difference was also observed in xanthine dehydrogenase activity, which was assayed in the presence of NAD. In most species, xanthine dehydrogenase activity of skin cytosol was higher than xanthine oxidase activity.

View this table:
  • View inline
  • View popup
TABLE 1

Aldehyde oxidase and xanthine oxidase/xanthine dehydrogenase activities in skin cytosols from various mammals

Each value represents the mean ± S.D. of four animals. Other details are described under Materials and Methods.

Nitroreduction of Nitro-PAHs in Skin Cytosols of Various Mammals. The 2-hydroxypyrimidine-linked nitroreductase activity toward NP and NB, as well as NF, was examined in skin cytosols of various mammals. These compounds were significantly reduced to the corresponding amines by skin cytosols of hamsters, rabbits, guinea pigs, rats, and mice. Relatively high activity was observed in mice and rats, whereas rabbits showed the lowest activity among other mammals (Table 2). This may be due to very low xanthine oxidoreductase activity. The activity observed with rats was inhibited by oxypurinol, and that in hamsters was inhibited by menadione (data not shown). NP and NB, as well as NF, were also reduced by aldehyde oxidase and xanthine oxidoreductase in skin cytosols of various mammals, but the contributions of the two flavoenzymes were different among species.

View this table:
  • View inline
  • View popup
TABLE 2

Nitroreductase activity toward nitro-PAHs in skin cytosols of various mammals

Each value represents the mean ± S.D. of three animals. The mixture containing 0.1 μmol of 1-nitropyrene or 4-nitrobiphenyl, 0.5 μmol of 2-hydroxypyrimidine, and skin cytosol in 0.1 M potassium/sodium phosphate buffer (pH 7.4) was incubated at 37°C for 30 min under an anaerobic condition. The amounts of 1-aminopyrene and 4-aminobiphenyl formed were determined by HPLC. Other details are described under Materials and Methods.

Discussion

Aldehyde oxidase, a cytosolic enzyme, contains FAD, molybdenum, and an iron-sulfur center, and is closely related to xanthine oxidoreductase (Turner et al., 1995; Hille, 2005). Both enzymes have similar primary and secondary structures, but their substrate specificities differ (Krenitsky et al., 1972; Beedham, 1985). Aldehyde oxidase can catalyze the oxidation of various aldehydes and nitrogenous heterocyclic compounds (Clarke et al., 1995; Jordan et al., 1999; Kitamura et al., 1999a), whereas xanthine oxidoreductase participates in purine metabolism such as caffeine, hypoxanthine, and 6-deoxyacyclovir (Krenitsky et al., 1984; Jones et al., 1987; Relling et al., 1992). Both enzymes in the presence of an electron donor can also mediate the reduction of a variety of compounds, such as sulfoxide, N-oxide, epoxide, and aromatic nitro compounds (Kitamura and Tatsumi, 1984; Tatsumi et al., 1986; Hirao et al., 1994; Sugihara et al., 1996). In a previous study, we demonstrated that NF was mainly reduced by xanthine oxidoreductase in the presence of 2-hydroxypyrimidine or 4-hydroxypyrimidine as an electron donor in skin of Sea/Sprague-Dawley strain rats, which exhibited high liver aldehyde oxidase activity (Ueda et al., 2003). However, in this study using hamster skin, 2-hydroxypyrimidine- and 4-hydroxypyrimidine-linked nitroreductase activities were slightly inhibited by an inhibitor of xanthine oxidoreductase and markedly inhibited by inhibitors of aldehyde oxidase. Moreover, electron donors to aldehyde oxidase enhanced the nitroreductase activity, showing that aldehyde oxidase plays an important role in the nitroreduction in hamster skin. In contrast, the activity in skin of guinea pigs was partially inhibited by oxypurinol and menadione. These results suggested that xanthine oxidoreductase mainly contributed to nitroreduction in skin of mice and rats, whereas both molybdenum hydroxylases contributed in skin of guinea pigs. Therefore, it appears that the patterns of participation of these molybdenum hydroxylases in nitroreduction in mammalian skin can be classified into three groups, i.e., 1) participation of mainly aldehyde oxidase (hamsters and rabbits), 2) participation of mainly xanthine oxidoreductase (mice and rats); and 3) participation of both molybdenum hydroxylases (guinea pigs) (Fig. 5).

A marked species difference exists in the liver aldehyde oxidase activity. We determined aldehyde oxidase activity using benzaldehyde as a substrate in skin cytosols from hamsters, rabbits, guinea pigs, mice, and rats, and clear species differences in the levels of the activity were observed. The aldehyde oxidase and xanthine oxidoreductase activities in skin of various species appeared to be complementary, i.e., when one was high, the other was low. In addition, the pattern of species difference observed in these experiments using skin cytosol was similar to that in liver, except that rats (Sea/Sprague-Dawley strain), which have high liver aldehyde oxidase activity, exhibited relatively high xanthine oxidoreductase and low aldehyde oxidase activity in skin cytosol. In humans, it was reported that methotrexate, benzaldehyde, N1-methylnicotinamide, and 6-methylpurine were metabolized by liver aldehyde oxidase (Rodrigues, 1994; Sugihara et al., 1997; Kitamura et al., 1999b), and famciclovir was metabolized by liver xanthine oxidoreductase (Fowles et al., 1994). Since human aldehyde oxidase and xanthine oxidoreductase both play important roles in the metabolism of exogenous compounds, they may both be involved in metabolism of nitro compounds, such as some hair dyes and various topically applied therapeutic antiviral agents and anticancer agents, in human skin (Van Duuren, 1980; Rashidi et al., 1997).

In this study, skin cytosols from various mammals also exhibited significant nitroreductase activity toward NP and NB. The highest activity toward NF was observed with hamsters, which also exhibited high aldehyde oxidase activity. On the other hand, the highest activities toward NP and NB were observed with rats, which exhibited high xanthine oxidoreductase activity. This substrate specificity of the nitroreduction observed in skin cytosol from various mammals presumably reflects the specificity of the two flavoenzymes i.e., aldehyde oxidase, in the reduction of NF and xanthine oxidoreductase in the reduction of NP and NB.

The tissue distributions and activities of molybdenum hydroxylases have been investigated extensively. Krenitsky et al. (1974) found no aldehyde oxidase activity in skin of Sprague-Dawley rats and rhesus monkeys. On the other hand, Kooij et al. (1992) reported that xanthine oxidoreductase was present in rat skin. Immunohistochemical analysis confirmed that xanthine oxidoreductase was distributed in epidermis, sebaceous glands, and hair follicle epithelium, whereas aldehyde oxidase was not detected in epidermis of Wistar rats (Moriwaki et al., 1996). Moreover, in mice, mRNA of aldehyde oxidase was detected in esophagus, lung, liver, and testis, but not skin (Kurosaki et al., 1999). In contrast, Terao et al. (2000) cloned cDNA for AOH1 and AOH2, novel molybdenum hydroxylases, and demonstrated that mRNA of AOH2 was present in the basal layer of the epidermis and hair follicle in mice. We detected aldehyde oxidase and xanthine oxidoreductase activities in skins of various mammals. However, the physiological roles of these enzymes are still unknown. Possible roles include homeostatic control of vitamins such as retinoids and other biologically active molecules, and elimination of biogenic wastes or breakdown products generated by ultraviolet radiation and other environmental stresses (Kishore and Boutwell, 1980; Siegenthaler et al., 1990; Beedham et al., 1995; Garattini et al., 2003).

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

Aldehyde oxidase- and xanthine oxidoreductase-catalyzed reduction of nitro-PAHs in skin cytosols from various mammals.

The present study has demonstrated that nitroreductase activities toward some nitro-PAHs in skin of various mammalian species are due to both aldehyde oxidase and xanthine oxidoreductase, and the species differences reflect differences of relative aldehyde oxidase and xanthine oxidoreductase activities. Although the physiological roles of aldehyde oxidase and xanthine oxidoreductase in skin are unknown, it is clear that both molybdenum hydroxylases play important roles in the metabolism of xenobiotics in skin.

Footnotes

  • This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Japanese Ministry of Education, Science, Sports and Culture, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.

  • Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.

  • doi:10.1124/dmd.105.005306.

  • ABBREVIATIONS: nitro-PAH, nitrated polycyclic aromatic hydrocarbon; NF, 2-nitrofluorene; NP, 1-nitropyrene; NB, 4-nitrobiphenyl; HPLC, high-performance liquid chromatography.

    • Received April 24, 2005.
    • Accepted May 31, 2005.
  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    Bauer SL and Howard PC (1990) The kinetics of 1-nitropyrene and 3-nitrofluoranthene metabolism using bovine liver xanthine oxidase. Cancer Lett 54: 37–42.
    OpenUrlCrossRefPubMed
  2. ↵
    Beedham C (1985) Molybdenum hydroxylases as drug-metabolizing enzyme. Drug Metab Rev 16: 119–156.
    OpenUrlCrossRefPubMed
  3. ↵
    Beedham C, Peet CF, Panoutsopoulos GI, Carter H, and Smith A (1995) Role of aldehyde oxidase in biogenic amine metabolism. Prog Brain Res 106: 345–353.
    OpenUrlPubMed
  4. ↵
    Beije B and Möller L (1988) 2-Nitrofluorene and related compounds: prevalence and biological effects. Mutat Res 196: 177–209.
    OpenUrlCrossRefPubMed
  5. ↵
    Clarke SE, Harrell AW, and Chenery RJ (1995) Role of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver. Drug Metab Dispos 23: 251–254.
    OpenUrlAbstract
  6. ↵
    El-Bayoumy K, Hecht SS, and Hoffmann D (1982) Comparative tumor initiating activity on mouse skin of 6-nitrobenzo[a]pyrene, 6-nitrochrysene, 3-nitroperylene, 1-nitropyrene and their parent hydrocarbons. Cancer Lett 16: 333–337.
    OpenUrlCrossRefPubMed
  7. ↵
    Fowles SE, Pratt SK, Laroche J, and Prince WT (1994) Lack of a pharmacokinetic interaction between oral famciclovir and allopurinol in healthy volunteers. Eur J Clin Pharmacol 46: 355–359.
    OpenUrlPubMed
  8. ↵
    Fu PP (1990) Metabolism of nitro-polycyclic aromatic hydrocarbons. Drug Metab Rev 22: 209–268.
    OpenUrlPubMed
  9. ↵
    Garattini E, Mendel R, Romão MJ, Wright R, and Terao M (2003) Mammalian molybdoflavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology. Biochem J 372: 15–32.
    OpenUrlCrossRefPubMed
  10. ↵
    Hille R (2005) Molybdenum-containing hydroxylases. Arch Biochem Biophys 433: 107–116.
    OpenUrlCrossRefPubMed
  11. ↵
    Hirao Y, Kitamura S, and Tatsumi K (1994) Epoxide reductase activity of mammalian liver cytosols and aldehyde oxidase. Carcinogenesis 15: 739–743.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Jones DB, Rustgi VK, Kornhauser DM, Woods A, Quinn R, Hoofnagle JH, and Jones EA (1987) The distribution of 6-deoxyacyclovir, a xanthine oxidase-activated prodrug of acyclovir, in the isolated perfused rat liver. Hepatology 7: 345–348.
    OpenUrlPubMed
  13. ↵
    Jordan CGM, Rashidi MR, Laljee H, Clarke SE, Brown JE, and Beedham C (1999) Aldehyde oxidase-catalyzed oxidation of methotrexate in the liver of guinea-pig, rabbit and man. J Pharm Pharmacol 51: 411–418.
    OpenUrlCrossRefPubMed
  14. ↵
    Kishore GS and Boutwell (1980) Enzymatic oxidation and reduction of retinal by mouse epidermis. Biochem Biophys Res Commun 94: 1381–1386.
    OpenUrlCrossRefPubMed
  15. ↵
    Kitamura S, Nakatani K, Sugihara K, and Ohta S (1999a) Strain differences of the ability to hydroxylate methotrexate in rats. Comp Biochem Physiol 122C: 331–336.
    OpenUrl
  16. ↵
    Kitamura S, Sugihara K, Nakatani K, Ohta S, Oh-hara T, Ninomiya S, Green CE, and Tyson CA (1999b) Variation of hepatic methotrexate 7-hydroxylase activity in animals and humans. IUBMB Life 48: 607–611.
    OpenUrlCrossRefPubMed
  17. ↵
    Kitamura S and Tatsumi K (1984) Involvement of liver aldehyde oxidase in the reduction of nicotinamide N-oxide. Biochem Biophys Res Commun 120: 602–606.
    OpenUrlCrossRefPubMed
  18. ↵
    Kooij A, Bosch KS, Frederiks WM, and Van Noorden CJ (1992) High levels of xanthine oxidoreductase in rat endothelial, epithelial and connective tissue cells. A relation between localization and function? Virchows Arch B Cell Pathol Incl Mol Pathol 62: 43–150.
    OpenUrl
  19. ↵
    Krenitsky TA, Hall WW, Miranda PD, Beauchamp LM, Schaeffer HJ, and Whiteman PD (1984) 6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir. Proc Natl Acad Sci USA 81: 3209–3213.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Krenitsky TA, Neil SM, Elion GB, and Hitchings GH (1972) A comparison of the specificities of xanthine oxidase and aldehyde oxidase. Arch Biochem Biophys 150: 585–599.
    OpenUrlCrossRefPubMed
  21. ↵
    Krenitsky TA, Tuttle JV, Cattau EL, and Wang P (1974) A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp Biochem Physiol B 49: 687–703.
    OpenUrlCrossRefPubMed
  22. ↵
    Kurosaki M, Demontis S, Barzago MM, Garanttini E, and Terao M (1999) Molecular cloning of the cDNA coding for mouse aldehyde oxidase: tissue distribution and regulation in vivo by testosterone. Biochem J 341: 71–80.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Möller L, Rafter J, and Gustafsson J-Å (1987) Metabolism of the carcinogenic air pollutant 2-nitrofluorene in the rat. Carcinogenesis 8: 637–645.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Moriwaki Y, Yamamoto T, Yamaguchi K, Takahashi S, and Higashino K (1996) Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies. Histochem Cell Biol 105: 71–79.
    OpenUrlCrossRefPubMed
  25. ↵
    Purohit V and Basu AK (2000) Mutagenicity of nitroaromatic compounds. Chem Res Toxicol 13: 673–692.
    OpenUrlCrossRefPubMed
  26. ↵
    Rashidi MR, Smith JA, Clarke SE, and Beedham C (1997) In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit and rat liver. Drug Metab Dispos 25: 805–813.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Relling MV, Lin J-S, Ayers GD, and Evans WE (1992) Racial and gender differences in N-acetyltransferase, xanthine oxidase and CYP1A2 activities. Clin Pharmacol Ther 52: 643–658.
    OpenUrlPubMed
  28. ↵
    Rodrigues AD (1994) Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochem Pharm 48: 197–200.
    OpenUrlCrossRefPubMed
  29. ↵
    Saito K, Kamataki T, and Kato R (1984) Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes. Cancer Res 44: 3169–3173.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Siegenthaler G, Gumowski-Sunek D, and Saurat JH (1990) Metabolism of natural retinoids in psoriatic epidermis. J Investig Dermatol 95: 47S–48S.
    OpenUrlCrossRefPubMed
  31. ↵
    Sugihara K, Kitamura S, and Tatsumi K (1995) Strain differences of liver aldehyde oxidase activity in rats. Biochem Mol Int 37: 861–869.
    OpenUrl
  32. ↵
    Sugihara K, Kitamura S, and Tatsumi K (1996) Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab Dispos 24: 199–202.
    OpenUrlAbstract
  33. ↵
    Sugihara K, Kitamura S, Tatsumi K, Asahara T, and Dohi K (1997) Differences in aldehyde oxidase activity in cytosolic preparations of human and monkey liver. Biochem Mol Biol Int 41: 1153–1160.
    OpenUrlPubMed
  34. ↵
    Tatsumi K, Kitamura S, and Narai N (1986) Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations. Cancer Res 46: 1089–1093.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Terao M, Kurosaki M, Saltini G, Demontis S, Marini M, Salmona M, and Garattini E (2000) Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase. J Biol Chem 39: 30690–30700.
    OpenUrl
  36. ↵
    Turner NA, Doyle WA, Ventom AM, and Bray RC (1995) Properties of rabbit liver aldehyde oxidase and the relationship of the enzyme to xanthine oxidase and dehydrogenase. Eur J Biochem 232: 646–657.
    OpenUrlPubMed
  37. ↵
    Ueda O, Kitamura S, Kubo R, Yano Y, Kanzaki Y, Fujimoto T, Tatsumi K, and Ohta S (2001) Metabolism of 2-nitrofluorene, 2-aminofluorene and 2-acetylaminofluorene in rat and dog and the role of intestinal bacteria. Xenobiotica 31: 33–49.
    OpenUrlCrossRefPubMed
  38. ↵
    Ueda O, Kitamura S, Ohashi K, Sugihara K, and Ohta S (2003) Xanthine oxidase-catalyzed metabolism of 2-nitrofluoren, a carcinogenic air pollutant, in rat skin. Drug Metab Dispos 31: 367–372.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Ueda O, Kitamura S, and Ohta S (2002) Metabolism of 2-nitrofluorene, an environmental pollutant, by liver preparations of sea bream, Pagrus major. Xenobiotica 32: 667–682.
    OpenUrlCrossRefPubMed
  40. ↵
    Van Duuren BL (1980) Carcinogenicity of hair dye components. J Environ Pathol Toxicol 3: 237–251.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (9)
Drug Metabolism and Disposition
Vol. 33, Issue 9
1 Sep 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
INVOLVEMENT OF MOLYBDENUM HYDROXYLASES IN REDUCTIVE METABOLISM OF NITRO POLYCYCLIC AROMATIC HYDROCARBONS IN MAMMALIAN SKIN
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

INVOLVEMENT OF MOLYBDENUM HYDROXYLASES IN REDUCTIVE METABOLISM OF NITRO POLYCYCLIC AROMATIC HYDROCARBONS IN MAMMALIAN SKIN

Osamu Ueda, Kazumi Sugihara, Shigeru Ohta and Shigeyuki Kitamura
Drug Metabolism and Disposition September 1, 2005, 33 (9) 1312-1318; DOI: https://doi.org/10.1124/dmd.105.005306

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

INVOLVEMENT OF MOLYBDENUM HYDROXYLASES IN REDUCTIVE METABOLISM OF NITRO POLYCYCLIC AROMATIC HYDROCARBONS IN MAMMALIAN SKIN

Osamu Ueda, Kazumi Sugihara, Shigeru Ohta and Shigeyuki Kitamura
Drug Metabolism and Disposition September 1, 2005, 33 (9) 1312-1318; DOI: https://doi.org/10.1124/dmd.105.005306
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Gene expression profile of human intestinal epithelial cells
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics